The firm explained that while it has offered immunology and cell research products since 1991, the new unit allows will boost distribution capacity of its range of culture reagents, assays, antibodies and proteins.
MD Biosciences president Eddie Madison said: “The launch of MD Bioproducts is a great step of convenience for our clients, accommodating them to optimize their research process.
“We know that our products offer accuracy and reproducibility so our clients can be confident in their results. Our quality reagents contribute to the success of our clients' research."
